ACAD
ACADIA Pharmaceuticals Inc
20.10$
+0.8%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 78.9% | 82.3% | 79.0% | 79.7% | 80.7% | 79.0% | 76.9% | 78.4% | 80.9% | 67.9% | 68.3% | 70.3% | |
| 15.5% | 25.2% | 23.9% | 19.4% | 15.9% | 26.9% | 19.2% | 20.7% | 19.4% | 11.4% | 17.6% | 22.1% | |
| 54.7% | 58.6% | 55.0% | 54.8% | 57.9% | 63.6% | 60.2% | 62.2% | 63.6% | 52.4% | 53.0% | 54.9% | |
| 14.9% | 13.7% | 11.7% | 12.1% | 10.1% | 8.8% | 10.0% | 9.8% | 10.5% | 9.5% | 9.2% | 9.5% | |
| 3.3% | 4.8% | 7.2% | 7.8% | 6.2% | 1.8% | 2.0% | 2.1% | 2.2% | 2.2% | 2.0% | 1.9% | |
| 8.8% | – | – | – | – | – | – | – | – | – | – | – | |
| – | 0.0% | – | – | – | – | – | – | – | – | – | – | |
| 10.6% | 8.7% | 12.9% | 11.8% | 10.8% | 10.1% | 10.3% | 9.3% | 8.4% | 7.0% | 6.6% | 5.9% | |
| 42.7% | 42.4% | 45.7% | 43.5% | 40.9% | 38.3% | 32.4% | 32.9% | 31.1% | 21.5% | 22.3% | 25.0% | |
| 33.1% | 33.9% | 38.7% | 37.0% | 35.2% | 33.2% | 26.7% | 26.9% | 26.8% | 17.7% | 19.0% | 20.7% | |
| 1.4% | 1.3% | 1.2% | 1.1% | 0.9% | 0.8% | 1.0% | 1.0% | 0.9% | 0.7% | 0.7% | 0.8% | |
| 1.9% | 2.3% | 2.3% | 2.2% | 2.0% | 1.4% | 1.6% | 1.6% | 1.6% | 0.7% | 0.8% | 2.6% | |
| 57.3% | 57.6% | 54.3% | 56.5% | 59.1% | 61.7% | 67.6% | 67.1% | 68.9% | 78.5% | 77.7% | 75.0% | |
| -391.5% | -324.6% | -282.3% | -260.5% | -240.4% | -185.6% | -193.0% | -176.1% | -156.8% | -115.9% | -112.7% | -102.0% | |
| 26.0% | 22.2% | 19.5% | 18.2% | 17.0% | 14.0% | 14.8% | 13.8% | 12.8% | 11.0% | 10.8% | 9.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.